Press Releases

 Filter by Provider

Skillsoft (NYSE: SKIL) (“Skillsoft” or the “Company”), the platform that empowers organizations and learners to unlock their full potential, today announced it has appointed John Frederick, the Company’s Chief Transformation Officer (CTO), as Chief Financial Officer, effective immediately. Mr. Frederick succeeds Rich Walker, who is stepping down to pursue other opportunities. To facilitate a smooth transition, Mr. Walker will serve in an advisory capacity until July 4, 2025.

Interface, Inc. (Nasdaq: TILE), the global flooring solutions company and leader in sustainability, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.01 per share, payable June 13, 2025 to shareholders of record as of May 30, 2025.

ESS Tech, Inc. (“ESS,” “ESS, Inc.” or the “Company”) (NYSE: GWH), a leading manufacturer of long-duration energy storage systems (LDES) for commercial and utility-scale applications, today announced financial results for its first quarter ended March 31, 2025.

First quarter 2025 gross margin, excluding FaZe Media of 22.8%

Today marks the official launch of OfficeOutlaw.com — a raw, fast-growing forum for people building agencies, brands, and digital products who are tired of the same copy-paste advice.

Volato Group, Inc. (NYSE American: SOAR) (“Volato” or the “Company”), a private aviation innovator, today announced financial results for the first quarter of 2025, achieving profitability from continuing operations and reducing total liabilities by over $20 million. The Company also disclosed its intention to raise additional equity and continue settling outstanding liabilities in order to extend its operating runway beyond 12 months. For the quarter ended March 31, 2025, Volato reported $25.5 million in revenue and net income of $0.5 million, or $0.03 per diluted share. Total liabilities declined from $62.6 million as of December 31, 2024 to $39.2 million, primarily as a result of disciplined debt reduction and asset sales.

National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today announced the settlement of the remaining $84.8 million aggregate principal amount of 2.5% unsecured convertible senior notes due May 15, 2025 (the “2025 Convertible Notes”). The settlement was made with $59.8 million from cash on hand and the remaining borrowed under the Company’s revolving credit facility.

Today Domo (Nasdaq: DOMO) announced that, for the seventh consecutive year, it is the top-ranked vendor in the Dresner Advisory Services’ 2025 Self-Service Business Intelligence (BI) Market Study.

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that management is scheduled to present at the 2025 RBC Capital Markets Global Healthcare Conference on Tuesday, May 20th at 8:30 a.m. ET. An audio webcast of the presentation can be accessed on the Investors section of Contineum’s website. A webcast replay will also be available.

National Storage Affiliates Trust (“NSA” or the "Company") (NYSE: NSA), announced that its Board of Trustees today declared regular cash dividends for the second quarter 2025 payable on June 30, 2025 to shareholders of record on June 13, 2025 on the following securities:

The Western Union Company (NYSE: WU) announced today that its board of directors declared a quarterly cash dividend of $0.235 per common share, payable June 30, 2025, to stockholders of record at the close of business on June 16, 2025.

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today provided a business update and reported financial results for the three months ended March 31, 2025.

The Arena Group Holdings, Inc. (NYSE American: AREN) (“Arena”), a technology platform and media company home to hundreds of media brands, including TheStreet, Parade, Men’s Journal, Athlon Sports, Surfer, Powder and more today announced financial results for the three months ending March 31, 2025 (“Q1 2025”).

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for traditional approval of FILSPARI (sparsentan) for the treatment of focal segmental glomerulosclerosis (FSGS). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of January 13, 2026, and has indicated that it is currently planning to hold an advisory committee meeting to discuss the application.

Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a...

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, today announced its financial results and business updates for the first quarter ended March 31, 2025. RenovoCath powers RenovoRx’s patented Trans-Arterial Micro-Perfusion (TAMP™) therapy platform.

Rambus Inc. (Nasdaq: RMBS), a provider of industry-leading chips and IP making data faster and safer, today announced that its executives will present at three upcoming investor events: the Baird 2025 Global Consumer, Technology & Services Conference; the BofA Securities 2025 Global Technology Conference; and the Rosenblatt 5th Annual Technology Virtual Summit.

Camping World Holdings, Inc. (NYSE: CWH) (the “Company” or “Camping World”) announced today that its Board of Directors declared a regular cash dividend of $0.125 per share on the Company’s Class A Common Stock. Payment is expected to be made on June 27, 2025 to stockholders of record at the close of business on June 13, 2025.

Mativ Holdings, Inc. (NYSE: MATV) today announced its participation in the following upcoming investor conferences:

Take-Two Interactive Software, Inc. (NASDAQ:TTWO) today reported results for the fourth quarter and fiscal year 2025, ended March 31, 2025. For further information, please see the fourth quarter and fiscal 2025 results slide deck posted to the Company’s investor relations website at take2games.com/ir.

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the first quarter ended March 31, 2025.

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced financial results for the first quarter ended March 31, 2025 and outlined operational highlights based on its newly expanded clinical pipeline.

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three months ended March 31, 2025.

International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that its Board of Directors has voted to increase the Company’s quarterly ordinary common share dividend to $0.05 per share, representing a 100% increase from the present rate of $0.025 per share per quarter.

Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the first quarter ended March 31, 2025.

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced plans to present at the upcoming Jefferies Global Healthcare Conference on Thursday, June 5th at 4:20pm Eastern Time (ET). Management will also be hosting in-person meetings on Wednesday, June 4th.

Build-A-Bear Workshop, Inc. (NYSE: BBW) today announced that the Company will report first-quarter fiscal 2025 results for the period ended May 3, 2025, on Thursday, May 29, 2025, before the opening of trading on the New York Stock Exchange. The Company will host its quarterly investor conference call to discuss the results at 9 a.m. ET on the same day.

Ulta Beauty, Inc. (NASDAQ: ULTA) today announced that its financial results for the first quarter of fiscal year 2025 will be released Thursday, May 29, 2025, after the market closes. The Company will host a webcast and conference call at 4:30 p.m. ET / 3:30 p.m. CT to discuss the financial results.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences.

ReposiTrak (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today announced financial results for the third fiscal quarter (“FQ3 2025”) ended March 31, 2025.

New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients 

JERSEY CITY, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company’s executive management team will present at the William Blair 45th Annual Growth Stock Conference in Chicago, Illinois. The presentation is scheduled for Wednesday, 6/4, at 8:00am CT.

Q1 2025 Revenue Growth of 111% Driven by New Products and Technologies

PHOENIX, May 15, 2025 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA: TILT) (OTCPK: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its financial and operating results for the three months ended March 31, 2025. All financial information is reported in U.S. dollars and prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) unless otherwise indicated.

PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today announced management is scheduled to participate in the following investor events:

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a leader in the development of industrial-scale data centers, today announced its participation in several upcoming industry conferences. Various members of the Cipher leadership team will be featured in discussions on the Company’s existing site capacity, growth strategy, Bitcoin mining and HPC opportunities. If the presentation will be webcast, a link to such webcast will be posted on the Company’s website at https://investors.ciphermining.com, as well as Cipher’s X and LinkedIn platforms ahead of each event.

Scales Import Operations, and Advances Diversification and Infrastructure Initiatives

Wabtec Corporation (NYSE: WAB) announced today that its Board of Directors declared a regular quarterly common dividend of 25 cents per share, payable on June 10, 2025, to holders of record on May 27, 2025.

As society’s reliance on electricity deepens, artificial intelligence (AI) is reshaping how we manage power grids and optimize energy sources. A recent workshop hosted by the U.S. Department of Energy’s Argonne National Laboratory brought together leading experts from national labs, universities, government agencies, and industry to explore the transformative potential of AI foundation models for electric grids.

SANTA CLARA, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. (NASDAQ: AMAT) today reported results for its second quarter ended Apr. 27, 2025.

Origin Materials, Inc. (“Origin,” “Origin Materials,” or the “Company”) (Nasdaq: ORGN, ORGNW), a technology company with a mission to enable the world’s transition to sustainable materials, today announced financial results for its first quarter ended March 31, 2025.

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced its financial results for the first quarter ended March 31, 2025, and announced the closure of new patient screening for the ongoing registrational Phase 3 PROSERA Study in PAH patients.

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 fourth quarter and fiscal year ended March 31, 2025.

Company reports first quarter 2025 revenue growth of 153% with 28% pro-forma adjusted EBITDA margin

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its first quarter 2025 financial results and provided a clinical update.

Expects Growth to Accelerate In Second QuarterReiterates 2025 Guidance

Delivered $1.9M in net income, a $5.3M year-over-year improvement, showcasing strong execution and margin gains

Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments